publication venue for
- Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity.. 23. 2024
- Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.. 22. 2023
- Contact tracing in acute hepatitis C: The source patient identification and group overlap therapy proof-of-concept pilot program.. 20. 2022
- Hepatitis C viral infection after liver transplantation.. 1. 2012
- COVID 19: Management of Decompensated Cirrhosis and Liver Transplant Recipients. 2020
- Time-Sensitive Interventions in Hospitalized Patients With Cirrhosis. 2020
- Microbiome Modulation in Liver Disease. 2019
- Geographic Areas of Liver Distribution in the United States Should Not Be Redesigned According to the 2016 Eight-District Organ Procurement and Transplantation Network Proposal. 2018
- Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. 2018
- Treatment of hepatitis C virus in advanced renal disease. 2017
- The extinction of chronic viral hepatitis? 2015
- Inpatient management of fluid overload (ascites, hepatic hydrothorax, and anasarca). 2024
- Noninvasive tests in the evaluation of nonalcoholic fatty liver disease: A review. 2023
- ERCP: a very personal history. 2023
- Improvement in nonalcoholic fatty liver disease through bariatric surgery. 2022
- Jaundice in Polycystic Liver Disease: More Than Meets the Eye. 2021
- Who Should Treat Fatty Liver Disease: Primary Care or Hepatology? 2019
- Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers. 2012